Authors:
GEHLING U
WEIMAR C
SCHULER U
RATHGEB F
EHNINGER G
SCHUMACHER K
HAVEMANN K
Citation: U. Gehling et al., PHASE I II STUDY OF DEXNIGULDIPINE AND DOXORUBICINE IN ADVANCED RENAL-CELL CARCINOMA (RCC)/, The FASEB journal, 9(3), 1995, pp. 96-96
Authors:
GEHLING U
RYDER J
HAMI L
HOGAN CJ
MCNIECE I
SHIEH JH
GRINGERI A
FRANKLIN W
WILLIAMS S
KING J
MCBURNIE E
SHPALL EJ
Citation: U. Gehling et al., EX-VIVO EXPANSION OF MEGAKARYOCYTE (MK) PROGENITORS USING RECOMBINANTHUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR (MGDF-B) IN VARIOUSGROWTH-FACTOR COMBINATIONS, Blood, 86(10), 1995, pp. 442-442
Authors:
WACKER CM
SCHAD LR
GEHLING U
GAMROTH AH
MULLER E
KNOPP MV
SCHULZ V
VANKAICK G
Citation: Cm. Wacker et al., THE PULMONARY-ARTERY ACCELERATION TIME DETERMINED WITH THE MR-RACE-TECHNIQUE - COMPARISON TO PULMONARY-ARTERY MEAN PRESSURE IN 12 PATIENTS, Magnetic resonance imaging, 12(1), 1994, pp. 25-31